Net delta exposure for Denali Therapeutics Inc (DNLI) options was -$548.17K per 1% move at the Nov 4, 2026 close. It has been positive on 1 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $118.96K.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for DNLI, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for DNLI, 2026-11-20(m), calls & puts
Net Delta Exposure by Expiration
Showing results for DNLI, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
DNLI Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is DNLI delta exposure positive or negative?
Denali Therapeutics net delta exposure was negative on Nov 4, 2026, at -$548.17K. It has been positive on 1 of the last 20 trading days.
How has DNLI delta exposure changed recently?
Denali Therapeutics net delta exposure went from $118.96K on Oct 7, 2026 to -$548.17K on Nov 4, 2026. See the DNLI delta exposure history for a longer view.
What is Denali Therapeutics Inc?
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases.